China NMPA Product Recall - Manual wheelchair

Anyang Zhongxin Medical Technology Co., Ltd., a medical device manufacturer, has initiated a voluntary recall of a specific batch of its manual wheelchairs. This action, publicly reported by the National Medical Products Administration (NMPA) on June 28, 2017, stems from a critical finding concerning product labeling. The primary violation identified was the non-compliance of the manual wheelchairs' labeling with established standard requirements. Accurate and compliant labeling is fundamental for medical devices, ensuring users receive correct information regarding product usage, safety, and specifications. The affected products are identifiable by batch number 20170107 and model SYIV-100-AH0. This recall is designated as a Level III recall, which typically signifies that while the product is non-compliant, its use or exposure is not likely to cause adverse health consequences. However, the company, operating under the regulatory framework supervised by the NMPA, promptly undertook this voluntary action to address the labeling discrepancies. The required action was the immediate recall of the non-compliant manual wheelchairs, demonstrating the company's commitment to regulatory adherence and product integrity. This measure ensures that all products distributed meet the necessary quality and informational standards mandated by the NMPA.